PEOPLE - Ostex International (US) is creating a European subsidiary based in UK and announces the following appointments:
This article was originally published in Clinica
Executive Summary
Ostex International (US) is creating a European subsidiary based in Manchester, UK. John Wynne becomes vice-president of European operations and Dr Victor Miranda is named director of Latin America sales. Mr Wynne was formerly with IMR and Dr Miranda with Lunar.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.